Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, SVY

Incode Technologies Recognized as #1 Technology for Age Estimation and Verification in Study by the National Institute of Standards and Technology


Announced as a leading solution for age estimation and verification at the Global Age Assurance Standards Summit

SAN FRANCISCO, May 30, 2024 /PRNewswire/ -- Incode, leader in identity verification technology, has been recognized as the top global solution for age estimation and verification in a study conducted by the National Institute of Standards and Technology (NIST). This recognition was announced at the Global Age Assurance Standards Summit.

Age estimation involves accurately predicting a user's age based on a picture, and is crucial for applications like protecting minors from online risks and ensuring compliance with age-restricted goods and services.

The NIST study, part of the Face Analysis Technology Evaluation (FATE)*, rigorously tested various age estimation and verification algorithms from leading international companies. This evaluation assessed the effectiveness of AI-driven facial biometric technologies, which can be challenging due to variations in lighting, facial expressions, and demographic factors.

Incode's age estimation technology demonstrated the highest performance metrics in crucial categories:

Ricardo Amper, CEO of Incode, stated: "Age estimation involves improving the way businesses interact with their users, and more importantly, keeping individuals safe online. This recognition from NIST not only reaffirms our leading position in the age verification market but also reflects our commitment to innovation and excellence. Our technology ensures that businesses can protect young users and comply with regulatory requirements without sacrificing user convenience and privacy."

Incode's AI-driven age verification solution offers a user-friendly experience, designed to be frictionless and intuitive ? reducing user error, minimizing drop-off rates, and maximizing completion to help businesses retain and acquire more customers. It can be easily customized to fit different use cases across various jurisdictions and industries, with three easy methods to verify a user's age:

Incode Technologies continues to innovate in the identity verification space, providing solutions that support a variety of industries, including financial services, online entertainment, social networks, and e-commerce. With over $220 million raised from notable investors like General Atlantic, Softbank, and JP Morgan, Incode is poised for further expansion and impact.

For more details, please visit www.incode.com/use-cases/age-verification.

* FATE is a comprehensive evaluation program that benchmarks the performance of facial recognition and analysis technologies, providing an impartial assessment of their accuracy and reliability.

About Incode
Incode offers an end-to-end identity verification and authentication platform, helping its clients distinguish good users from fraudulent ones, effortlessly. Incode ensures customers' security and compliance goals are met, so they can focus on their growth objectives. Incode's fully automated, AI-first platform is built for low friction of genuine users, coupled with instant verification and re-engagement tools that drive conversions. Its multi-layer identity platform combines proprietary AI technology, deterministic identity checks, and advanced deepfake detection to combat the most sophisticated fraud.

With over $220 million raised from investors such as General Atlantic, Softbank, and JP Morgan, Incode's vision to "power a world of trust" is rapidly gaining global adoption. Based in San Francisco, with offices and operations worldwide, Incode is partnering with the most innovative brands to connect businesses with high-quality, low-risk customers. 

Schedule a demo at www.incode.com/schedule-demo

SOURCE Incode Technologies


These press releases may also interest you

at 09:13
Methodist Le Bonheur Healthcare announced Methodist University Hospital earned top recognition by Money magazine as one of the Best U.S. Hospitals for Cardiac Care. The Memphis-based healthcare system's academic flagship landed 15th out of 75 and is...

at 09:06
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...

at 09:03
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...

at 09:00
In March 2024, dairy cows in Texas were found to be infected with highly pathogenic avian flu, or H5N1 bird flu, in the first known case of the virus spreading to cattle. Since then, H5N1 has been found in about 200 animals?and 3 people?across 12...

at 09:00
Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2023....

at 09:00
Global health company The Cigna Group will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day....



News published on and distributed by: